\-\ Texto\\:\\ \ \(0\)\
\-\ none\\ provided\ \(5\)\
\-\ there\\ is\\ a\\ large\\ heterogenous\\ presacral\\ mass\\ that\\ contains\\ gross\\ regions\\ of\\ fat\\ within\\ it\\.\\ no\\ invasion\\ of\\ surrounding\\ osseous\\ structures\\.\\ \\ there\\ is\\ no\\ abdominal\\ or\\ pelvic\\ adenopathy\\.\ \(0\)\
\-\ extramedullary\\ hematopoiesis\ \(4\)\
\-\ \\â\\€\\¢\\ metastatic\\ lesion\\ \\(from\\ patient\\'s\\ prior\\ rcc\\)\ \(0\)\
\-\ \\â\\€\\¢\\ second\\ primary\\ neoplasm\\ \\(e\\.g\\.\\ sarcoma\\)\ \(0\)\
\-\ \\â\\€\\¢\\ extramedullary\\ hematopoiesis\ \(0\)\
\-\ 79\\ y\\/o\\ woman\\ for\\ follow\\ up\\ after\\ left\\ nephrectomy\\ for\\ renal\\ cell\\ carcinoma\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hematopoiesis\\:\\ 0\\.19785236492220967\ \(0\)\
\-\ extramedullary\\:\\ 0\\.1625632672181148\ \(0\)\
\-\ presacral\\:\\ 0\\.10868881880701955\ \(0\)\
\-\ rcc\\:\\ 0\\.0812816336090574\ \(0\)\
\-\ 79\\:\\ 0\\.0767355294926764\ \(0\)\
\-\ nephrectomy\\:\\ 0\\.06824262690724474\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.06621187401109385\ \(0\)\
\-\ contains\\:\\ 0\\.06432427016784703\ \(0\)\
\-\ e\\.g\\:\\ 0\\.06373322511011419\ \(0\)\
\-\ heterogenous\\:\\ 0\\.06175636091722794\ \(0\)\
\-\ invasion\\:\\ 0\\.05795828250949411\ \(0\)\
\-\ gross\\:\\ 0\\.05733220134652462\ \(0\)\
\-\ regions\\:\\ 0\\.05507385416236717\ \(0\)\
\-\ adenopathy\\:\\ 0\\.05358990323760905\ \(0\)\
\-\ sarcoma\\:\\ 0\\.05358990323760905\ \(0\)\
\-\ provided\\:\\ 0\\.05191013674709049\ \(0\)\
\-\ osseous\\:\\ 0\\.05110045941022173\ \(0\)\
\-\ pelvic\\:\\ 0\\.04939789755725765\ \(0\)\
\-\ structures\\:\\ 0\\.046338950490629784\ \(0\)\
\-\ second\\:\\ 0\\.046227168101957435\ \(0\)\
\-\ neoplasm\\:\\ 0\\.04098812078749195\ \(0\)\
\-\ surrounding\\:\\ 0\\.03956570794879951\ \(0\)\
\-\ follow\\:\\ 0\\.038242246083752596\ \(0\)\
\-\ fat\\:\\ 0\\.036604398913825824\ \(0\)\
\-\ renal\\:\\ 0\\.036161627457155905\ \(0\)\
\-\ there\\:\\ 0\\.03582297342154898\ \(0\)\
\-\ primary\\:\\ 0\\.03565329947740418\ \(0\)\
\-\ carcinoma\\:\\ 0\\.034111657324167134\ \(0\)\
\-\ y\\/o\\:\\ 0\\.03333280323689635\ \(0\)\
\-\ cell\\:\\ 0\\.03251043255748572\ \(0\)\
\-\ up\\:\\ 0\\.0323640443810454\ \(0\)\
\-\ prior\\:\\ 0\\.030902996791582583\ \(0\)\
\-\ metastatic\\:\\ 0\\.030297315543888596\ \(0\)\
\-\ abdominal\\:\\ 0\\.030083369551015707\ \(0\)\
\-\ none\\:\\ 0\\.02985520432264798\ \(0\)\
\-\ woman\\:\\ 0\\.027801449964632484\ \(0\)\
\-\ it\\:\\ 0\\.027054202599056575\ \(0\)\
\-\ \\'s\\:\\ 0\\.02653586786432458\ \(0\)\
\-\ large\\:\\ 0\\.026317499039874362\ \(0\)\
\-\ after\\:\\ 0\\.024901425388862006\ \(0\)\
\-\ lesion\\:\\ 0\\.024514862338034574\ \(0\)\
\-\ no\\:\\ 0\\.0242378634001071\ \(0\)\
\-\ within\\:\\ 0\\.022959597301212418\ \(0\)\
\-\ that\\:\\ 0\\.02078846096561723\ \(0\)\
\-\ for\\:\\ 0\\.020538257708245498\ \(0\)\
\-\ \\(\\:\\ 0\\.020348217640672128\ \(0\)\
\-\ \\)\\:\\ 0\\.02009965329896634\ \(0\)\
\-\ from\\:\\ 0\\.017837122720481866\ \(0\)\
\-\ mass\\:\\ 0\\.016738887421796685\ \(0\)\
\-\ is\\:\\ 0\\.015839176855907765\ \(0\)\
\-\ or\\:\\ 0\\.014105954210756444\ \(0\)\
\-\ left\\:\\ 0\\.013466271398210067\ \(0\)\
\-\ patient\\:\\ 0\\.012064675083329408\ \(0\)\
\-\ a\\:\\ 0\\.005585912701670441\ \(0\)\
\-\ of\\:\\ 0\\.003281797205577139\ \(0\)\
\-\ \\.\\:\\ 0\\.0024999673307990336\ \(0\)\
